Drug rebates for insurers tied to higher costs for patients, especially the uninsured

Big rise in U.S. teens identifying as gay, bisexual
15 June 2021
Financial distress similar, or greater, for patients with heart disease compared to cancer
15 June 2021

Drug rebates for insurers tied to higher costs for patients, especially the uninsured

Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower drug costs for insurers has led to increases in list prices and out-of-pockets costs for patients.

Comments are closed.